Skip to main content
Premium Trial:

Request an Annual Quote

Applied BioCode, EraGen Reach MDx Pact

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Applied BioCode is providing EraGen Biosciences access to its Barcoded Magnetic Bead technology and the CE-marked BioCode -1000 system under a partnership and licensing agreement announced today.

The technology provides a solution for development and clinical laboratory use of multiplexed infectious disease and genetic tests, Applied BioCode said. Its President, Winston Ho, added in a statement that the combination of his firm's technology with EraGen's patented chemistry is expected to result in a "powerful testing platform for clinical laboratories."

Financial and other terms of the deal were not disclosed.

"We look forward to commercializing molecular diagnostics that address not only customers needing real-time molecular testing, but also those in the growing segment that need highly multiplexed in vitro diagnostics," Irene Hrusovsky, chairperson and chief executive of EraGen, added.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.